Listed

Angiodynamics Inc

ANGONasdaqCIK 1275187HealthcareFiscal year ends May 31

Reports and events: 312 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Angiodynamics Inc, Reports and events
FiledFormWhat it isAccession number
2017-09-2810:25 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-17-001304
2017-09-2808:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000914121-17-001302
2017-09-0711:09 ETDEF 14AProxy statementPeriod 2017-10-170001275187-17-000029
2017-08-0416:19 ET8-K/A2.02 Results of operations; 9.01 Financial statements and exhibits0000914121-17-001040
2017-08-0415:12 ET10-KAnnual reportPeriod 2017-05-310001275187-17-000026
2017-07-2517:30 ET10-Q/AQuarterly report, amendedPeriod 2017-02-280001275187-17-000022
2017-07-2517:21 ET10-Q/AQuarterly report, amendedPeriod 2016-11-300001275187-17-000020
2017-07-2517:08 ET10-Q/AQuarterly report, amendedPeriod 2016-08-310001275187-17-000018
2017-07-2517:01 ET10-K/AAnnual report, amendedPeriod 2016-05-310001275187-17-000016
2017-07-1807:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000914121-17-000940
2017-07-1806:53 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-17-000938
2017-07-1716:45 ET8-K8.01 Other events0000914121-17-000935
2017-04-2817:26 ETSC 13D/AOwnership report, active investor, amended0001193125-17-148966
2017-04-1416:47 ETSC 13D/AOwnership report, active investor, amended0001193125-17-124759
2017-04-1212:12 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000914121-17-000469
2017-04-0607:10 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-17-000440
2017-04-0310:55 ET10-QQuarterly reportPeriod 2017-02-280001275187-17-000008
2017-03-3008:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000914121-17-000401
2017-01-1011:17 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-17-000022
2017-01-0615:06 ET10-QQuarterly reportPeriod 2016-11-300001275187-17-000005
2017-01-0612:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000914121-17-000018
2016-11-2216:21 ETSC 13D/AOwnership report, active investor, amended0001193125-16-775096
2016-11-1816:07 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0000914121-16-001680
2016-11-1016:10 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0000914121-16-001647
2016-10-2816:13 ET8-K5.07 Shareholder vote results0000914121-16-001612
2016-10-0719:33 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0000914121-16-001523
2016-10-0517:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000914121-16-001512
2016-10-0513:31 ET10-QQuarterly reportPeriod 2016-08-310001275187-16-000037
2016-09-1516:16 ETDEF 14AProxy statementPeriod 2016-10-250001193125-16-710999
2016-09-0816:56 ET8-K/A5.02 Departure or appointment of officers or directors0000914121-16-001457
2016-08-0516:45 ETSC 13D/AOwnership report, active investor, amended0001193125-16-673565
2016-08-0516:14 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000914121-16-001389
2016-08-0109:09 ET10-KAnnual reportPeriod 2016-05-310001275187-16-000034
2016-07-2821:13 ET8-K5.02 Departure or appointment of officers or directors0000914121-16-001381
2016-07-2516:49 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000914121-16-001373
2016-07-1314:28 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000914121-16-001347
2016-04-2716:10 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000914121-16-001150
2016-04-2008:50 ET8-K5.02 Departure or appointment of officers or directors0000914121-16-001122
2016-04-1116:26 ET10-QQuarterly reportPeriod 2016-02-290001275187-16-000030
2016-04-0817:43 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000914121-16-001076
2016-04-0620:50 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000914121-16-001069
2016-01-1310:26 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-16-000733
2016-01-0816:28 ET10-QQuarterly reportPeriod 2015-11-300001275187-16-000026
2016-01-0716:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000914121-16-000700
2015-11-0916:26 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000914121-15-000576
2015-11-0216:47 ET8-K5.07 Shareholder vote results0000914121-15-000561
2015-10-2116:44 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0000914121-15-000548
2015-10-1516:24 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-15-000537
2015-10-0817:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000914121-15-000503
2015-10-0816:36 ET10-QQuarterly reportPeriod 2015-08-310001275187-15-000022

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 20:24 ET. Listed shows no prices and gives no investment advice.